Atherosclerosis
Volume 210, Issue 1 , Pages 45-47 , May 2010

Exploring interactions among metabolic syndrome traits. Methods and meaning

Received 16 February 2010 ,Accepted 16 February 2010.

References 

  1. Avogaro P, Crepaldi G, Enzi G, Tiengo A. Association of hyperlipidemia, diabetes mellitus and moderate obesity. Acta Diabetol Lat. 1967;4:572–590
  2. Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  3. Avogaro A. Insulin resistance: trigger or concomitant factor in the metabolic syndrome. Panminerva Med. 2006;48:3–12
  4. Neels JG, Olefsky JM. Inflamed fat: what starts the fire?. J Clin Invest. 2006;116:33–35
  5. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005;48:1684–1699
  6. Inchiostro S, Fadini GP, de Kreutzenberg SV, Citroni N, Avogaro A. Is the metabolic syndrome a cardiovascular risk factor beyond its specific components?. J Am Coll Cardiol. 2007;49:2465;[author reply: 2465–2466]
  7. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–390
  8. Sundstrom J, Riserus U, Byberg L, et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006;332:878–882
  9. Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004;43:1388–1395
  10. Sundstrom J, Vallhagen E, Riserus U, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care. 2006;29:1673–1674
  11. Franco OH, Massaro JM, Civil J, et al. Trajectories of entering the metabolic syndrome: the Framingham heart study. Circulation. 2009;120:1943–1950
  12. Baldassarre D, Werba JP, Castelnuovo S, et al. The metabolic syndrome predicts carotid intima-media thickness no better than the sum of individual risk factors in a lipid clinic population. Atherosclerosis. 2010;
  13. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999;30:841–850
  14. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20:575–579
  15. Fadini GP, Coracina A, Inchiostro S, et al. A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. Eur J Cardiovasc Prev Rehabil. 2008;15:190–196
  16. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103:506–511
  17. Chakraborti S, Chakraborti T. Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: a brief overview. Cell Signal. 1998;10:675–683
  18. Wolfrum S, Dendorfer A, Rikitake Y, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004;24:1842–1847
  19. Kitamoto S, Egashira K, Kataoka C, et al. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. Circulation. 2000;102:806–812

PII: S0021-9150(10)00162-0

doi: 10.1016/j.atherosclerosis.2010.02.021

Atherosclerosis
Volume 210, Issue 1 , Pages 45-47 , May 2010

Article Tools

* Image Usage & Resolution